![Eric D. Lynch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Eric D.
Lynch is the founder of Sound Pharmaceuticals, Inc. which was founded in 2002.
He held the titles of Board Member, Vice President & Research Director from 2009 to 2010.
Dr. Lynch's former jobs include being a Research Director at Otogene and a Principal at the University of Washington.
Dr. Lynch received a doctorate degree from the University of California, Berkeley.
Anciens postes connus de Eric D. Lynch
Sociétés | Poste | Fin |
---|---|---|
Sound Pharmaceuticals, Inc.
![]() Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Fondateur | 01/12/2017 |
Otogene | Directeur Technique/Scientifique/R&D | - |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formation de Eric D. Lynch
University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Sound Pharmaceuticals, Inc.
![]() Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
Otogene |